AstraZeneca PLC

Common Name
AstraZeneca
Country
United Kingdom
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
94,300
Ticker
AZN
Exchange
LONDON STOCK EXCHANGE
Description
AstraZeneca PLC is a multinational pharmaceutical and biopharmaceutical company known for its extensive research-driven approach to drug development. The company focuses on the discovery, development,...

AstraZeneca's Climate Target Data Preview

As of 2024, AstraZeneca has disclosed 8 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 8 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into AstraZeneca ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
a
2026
Absolute-based Target
Scope 3 - Upstream Transportation and Distribution (Cat. 4), Scope 3 - Business Travel (Cat. 6)
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
a
2030
Absolute-based Target
Scope 3 - Fuel- and Energy-Related Services (Cat. 3), Scope 3 - Upstream Leased Assets (Cat. 8)
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
a
2030
Absolute-based Target
Scope 3 - End-of-Life Treatment of Sold Products (Cat. 12)
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
a
2030
Absolute-based Target
Scope 3 - Total Upstream (Cat. 1+2+3+4+5+6+7+8), Scope 3 - Downstream Transportation and Distribution (Cat. 9), Scope 3 - Use of Sold Products (Cat. 11), Scope 3 - End-of-Life Treatment of Sold Products (Cat. 12), Scope 3 - Downstream Leased Assets (Cat. 13)
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
a
2030
Absolute-based Target
Scope 3 - Purchased Goods and Services (Cat. 1)
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
a
2030
Absolute-based Target
Scope 3 - Use of Sold Products (Cat. 11)
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
a
2030
Absolute-based Target
Scope 3 - Total Upstream (Cat. 1+2+3+4+5+6+7+8), Scope 3 - Downstream Transportation and Distribution (Cat. 9), Scope 3 - Use of Sold Products (Cat. 11), Scope 3 - End-of-Life Treatment of Sold Products (Cat. 12), Scope 3 - Downstream Leased Assets (Cat. 13)
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
a
2045
Download AstraZeneca's Climate Targets data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind AstraZeneca’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore AstraZeneca’s data sources below and access millions more through our Disclosure Search.

a. AstraZeneca's Sustainability Data Spreadsheet 2024
Trace every data point back to AstraZeneca’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into AstraZeneca's Greenhouse Gas Emissions Pathways

As of 2024, AstraZeneca has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint. a

Does AstraZeneca have a target to reduce the emissions from its operations?

As of 2024, AstraZeneca has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources. a

AstraZeneca's most ambitious operational target is to reduce these emissions by 98% by 2026, compared to a baseline of 620,818 Metric Tonnes of CO2 equivalent (mtCO2e) in 2015. a

As of 2024, AstraZeneca is lagging behind on its operational emissions reduction target, having achieved 79.09% of the planned reduction. a

AstraZeneca's Operational (Scope 1+2) Emissions Pathway

2015202420260200 k400 k600 k800 kBaselineCurrent (-78%)Target 2026 (-98%)

Does AstraZeneca have a target to reduce the emissions from its value chain?

As of 2024, AstraZeneca has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol. a

AstraZeneca's most ambitious value chain target is to reduce these emissions by 95% by 2030, compared to a baseline of 1,037,501 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019. a

Instead of reducing value chain emissions, AstraZeneca has increased them, with 2024 levels exceeding those of the 2019 baseline, placing the company well behind its reduction target. a

AstraZeneca's Value Chain (Scope 3) Emissions Pathway

2019202420300350 k700 k1.05 M1.4 MBaselineCurrent (+33%)Target 2030 (-95%)
Want Full Access to AstraZeneca's Climate Targets Dataset?
Sign Up